View in EDS

In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenografts.

Saved in:
Bibliographic Details
Title: In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenografts.
Authors: Randall J; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia., Evans K; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia., Watts B; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia., Kosasih HJ; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia., Smith CM; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia., Earley EJ; RTI International, Research Triangle Park, Research Triangle, NC., Erickson SW; RTI International, Research Triangle Park, Research Triangle, NC., Jocoy EL; The Jackson Laboratory, Sacramento, CA., Bult CJ; The Jackson Laboratory, Bar Harbor, ME., Teicher BA; National Cancer Institute, Bethesda, MD., de Bock CE; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia., Smith MA; National Cancer Institute, Bethesda, MD., Lock RB; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia. Electronic address: rlock@ccia.org.au.
Source: Experimental hematology [Exp Hematol] 2024 Apr; Vol. 132, pp. 104176. Date of Electronic Publication: 2024 Feb 05.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2399 (Electronic) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38320689
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenografts.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Randall+J%22">Randall J</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Evans+K%22">Evans K</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Watts+B%22">Watts B</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Kosasih+HJ%22">Kosasih HJ</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Smith+CM%22">Smith CM</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Earley+EJ%22">Earley EJ</searchLink>; RTI International, Research Triangle Park, Research Triangle, NC.<br /><searchLink fieldCode="AU" term="%22Erickson+SW%22">Erickson SW</searchLink>; RTI International, Research Triangle Park, Research Triangle, NC.<br /><searchLink fieldCode="AU" term="%22Jocoy+EL%22">Jocoy EL</searchLink>; The Jackson Laboratory, Sacramento, CA.<br /><searchLink fieldCode="AU" term="%22Bult+CJ%22">Bult CJ</searchLink>; The Jackson Laboratory, Bar Harbor, ME.<br /><searchLink fieldCode="AU" term="%22Teicher+BA%22">Teicher BA</searchLink>; National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22de+Bock+CE%22">de Bock CE</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Smith+MA%22">Smith MA</searchLink>; National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Lock+RB%22">Lock RB</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, University of New South Wales Medicine & Health, Centre for Childhood Cancer Research, University of New South Wales Sydney, Sydney, NSW, Australia. Electronic address: rlock@ccia.org.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220402313%22">Experimental hematology</searchLink> [Exp Hematol] 2024 Apr; Vol. 132, pp. 104176. <i>Date of Electronic Publication: </i>2024 Feb 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Inc%22">Elsevier Science Inc </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0402313 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2399 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220301472X%22">0301472X </searchLink><i>NLM ISO Abbreviation: </i>Exp Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38320689
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.exphem.2024.104176
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104176
    Titles:
      – TitleFull: In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenografts.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Randall J
      – PersonEntity:
          Name:
            NameFull: Evans K
      – PersonEntity:
          Name:
            NameFull: Watts B
      – PersonEntity:
          Name:
            NameFull: Kosasih HJ
      – PersonEntity:
          Name:
            NameFull: Smith CM
      – PersonEntity:
          Name:
            NameFull: Earley EJ
      – PersonEntity:
          Name:
            NameFull: Erickson SW
      – PersonEntity:
          Name:
            NameFull: Jocoy EL
      – PersonEntity:
          Name:
            NameFull: Bult CJ
      – PersonEntity:
          Name:
            NameFull: Teicher BA
      – PersonEntity:
          Name:
            NameFull: de Bock CE
      – PersonEntity:
          Name:
            NameFull: Smith MA
      – PersonEntity:
          Name:
            NameFull: Lock RB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2024 Apr
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2399
          Numbering:
            – Type: volume
              Value: 132
          Titles:
            – TitleFull: Experimental hematology
              Type: main
ResultId 1